Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Shuangjun Biotechnology is a leading Chinese biotechnology company specializing in the research, development, and large-scale production of bioactive ingredients through advanced fermentation technologies. The company is globally recognized for its high-purity Vitamin K2 (Menaquinone-7), Nattokinase, and poly-gamma-glutamic acid (γ-PGA). Shuangjun Biotech operates state-of-the-art GMP-certified manufacturing facilities and maintains a strong focus on clinical research to validate the efficacy of its products in bone and cardiovascular health. Their business model encompasses both the supply of raw materials to the global nutraceutical industry and the development of finished health products. As a pioneer in the industrialization of MK-7 in China, the company holds extensive intellectual property and international certifications. They serve a diverse clientele across North America, Europe, and Asia, positioning themselves as a key player in the global functional food and supplement market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Shuangjun Biotechnology.